First there were Victoza and Saxenda, then Ozempic seized the spotlight - followed by Wegovy and Mounjaro. And ever-better ...
In the FTSE 250 index, PayPoint shares rose 6% or 42p to 716p after Royal Mail owner IDS agreed to take a 49% stake in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results